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Aim: This article is a report of a study evaluating changes in health status before and after topical ginger treatment for adults with moderate to severe osteoarthritis. Method: In 2011, 20 adults with
chronic osteoarthritis were randomly assigned to one of two groups for 7 consecutive days of topical
ginger treatment by trained nurses: Group 1 received a manually prepared ginger compress and Group
2 a standardized ginger patch. Participants had the option to continue self-treatment using the ginger
patch for a further 24 weeks. A brief arthritis health questionnaire was completed weekly for 3 weeks
and 4 weekly for 24 weeks. Results: The mean scores for Group 1 and Group 2 show a notable decline
following 1-week topical ginger treatment; scores in pain, fatigue, global effect, and functional status
reduced by 48%, 49%, 40%, and 31%, respectively, whereas health satisfaction improved from 80% dissatisfied to 70% satisfied. Scores for all participants in all five domains progressively reduced over the
following 24 weeks of self-treatment. Conclusion: Topical ginger treatment has the potential to relieve
symptoms, improve the overall health, and increase independence of people with chronic osteoarthritis.
Keywords: older adults; alternative therapies; chronic pain; herbal remedies; chronic conditions

Osteoarthritis (OA) is a chronic degenerative
disease of the articular cartilage primarily affecting
the hips, knees, and hands that subsequently
accounts for the majority of joint replacements and
musculoskeletal pain and disability in Western society (Zhang, Moskowitz, et al., 2008). OA is most
prevalent in those over 65 years, especially females,
and accounts for more problems while climbing
stairs and walking as well as lost efficacy at work
than any other disease (Bijlsma, Berenbaum, &
Lafeber, 2011). The chronic pain and disability
caused by OA often leads to compounding health
issues, such as chronic tiredness, inability to cope
with life, anxiety, and depression that need to be
considered in the overall management (Lane et al.,
2011). Research shows that people with OA choose
to use more complementary alternative medicines
than for any other chronic health condition
(Henderson, 2004; Lapane, Sands, Yang, McAlindon,
& Eaton, 2012), and there is a preference for topical
applications (Callahan et al., 2009; Herman, Craig,
& Caspi, 2005). Ginger has been identified as hav-

ing a role as an antiarthritic agent through its
antithrombotic and anti-inflammatory effects (Ali,
Blunden, Tanira, & Nemmar, 2008; Terry, Posadzki,
Watson, & Ernst, 2011), and there is limited research
showing beneficial effects from topical ginger applications in OA (Therkleson, 2010a).
The purpose of this study is to advance research
on the association between topical ginger treatment
using either a traditional manually prepared ginger
compress or a standardized ginger patch and the
relief of OA symptoms. Although internal ginger
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extract has been found effective in managing subjective experiences of pain and functional impairment in OA (Fajardo & Di Cesare, 2005; Terry et
al., 2011), the high doses required often cause
gastrointestinal disturbances (Marcus & SuarezAlmazor, 2001; Wigler, Grotto, Caspi, & Yaron,
2003). Topical ginger avoids these potential negative effects, and when applied over the mid-lumbar
region, qualitative studies suggest a positive effect
on mobility, mood, energy levels, and overall sense
of well-being (Therkleson, 2010b; Therkleson &
Sherwood, 2004). Topical ginger applied as ginger
compresses to the kidney region is part of the practice of anthroposophic nursing for patients with
chronic inflammatory conditions such as arthritis.
In 1923, anthroposophic nursing was founded in
the Ita Wegman Clinic in Arlesheim, Switzerland,
and today there are more than 25 specialist hospitals and clinics throughout Europe, with nursing
practice summarized in Fingado (2011, 2012).
Anthroposophic nurses are registered practicing
nurses, who have completed postgraduate education to advance their understanding of the anthroposophical perspective in health and illness as
introduced in Steiner and Wegman (1925/1967).
Since 1996 in New Zealand, there have been
courses educating registered practicing nurses in
anthroposophic nursing theory and practice
(Therkleson, 2007).
This study is the first known quantitative study
of topical ginger treatments for people with OA. In
early 2013, a database search for “topical ginger”
was done on a wide range of sources: Pub Med
Central,
Elsevier-Science
Direct,
Medline,
Cumulative Index to Nursing and Allied Health
Literature (CINHL), Web of Science, and Blackwell
Synergy. Ginger patches were developed to enhance
the reliability of results and to ensure that replication was possible in the home, with the minimum of
effort from participants.

Method and Materials
Aim
The aim of this study is twofold: (a) to evaluate
a standardized ginger patch alongside that of a traditional manually prepared ginger compress over 7
consecutive days in a clinic by using a simple, brief
arthritis questionnaire and (2) to evaluate the use of

the ginger patch at home for over 24 weeks using a
simple, brief arthritis questionnaire.
The secondary aims are to
• Evaluate and compare changes in participant
perception of pain intensity, chronic fatigue,
global effect of OA, mobility, and overall
satisfaction with health
• Evaluate participant changes in the use of
pain medication and/or pain management
• Evaluate the safety of the application of both
the ginger patch and ginger compress through
participant and nurse written reports

Design
Part 1. In 2011, a 3-week, open-label, two-group
study using three brief self-report questionnaires
(SRQ) was used to evaluate participants’ perceived
response to topical ginger treatments. Throughout
the 3 weeks, participants maintained their normal
established OA management procedures. Routine
analgesic medication was noted in a daily diary
alongside a daily pain questionnaire.
Twenty volunteer adults with OA were randomly
assigned to either Group 1 (compress) or Group 2
(patch). Randomization was sequential in time as
participants were recruited at the first interview.
This is a two-group design with a 1:1 allocation to
each of the two interventions; Group 1 had 10
receiving a manually prepared ginger compress, and
Group 2 had 10 receiving the standardized ginger
patch. To ensure equal numbers in each group, a
restricted randomized scheme was used, with a
block size of 4 (Machin & Fayers, 2010).
The intervention was 7 consecutive days of topical ginger treatments, given at four medical clinics
by anthroposophic nurses. Topical ginger treatment
was the same for all participants and involved lying
on the back in a quiet, warm space, with a prewarmed ginger patch/compress applied to the midlumbar region for 30 minutes, followed by a rest of
20 minutes. The compress and standardized patch
each had the equivalent of 1 g dry ground organic
Zingiber officinale rhizome (ginger) from the same
certified batch. The compress was prepared prior to
use by dissolving 10 g of ground ginger in 100 mL
hot water, soaking a cloth in the mixture and squeezing firmly. The patches were prepared exclusively for
the study: each comprising a piece of crepe paper
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and extract with 1 g ginger and purified water. The
same procedure and protocol for topical ginger compress treatments used in a previous qualitative study
for 10 people with OA was followed (Therkleson,
2010b). Before and after each treatment, nurses
monitored participants’ basic physiological measures
of temperature, pulse, respiration, blood pressure,
and body weight and the observed and reported
effects of the intervention. Although there are no
known risks or side effects to ginger therapy, this
was an added precaution. The brief Modified Health
Assessment Questionnaire (MHAQ) was completed
weekly for the first 3 weeks: 1 week before treatment, 12 hours after treatment, and 1 week after
treatment.
Part 2. Following the initial 3 weeks, all participants
were offered the option to continue self-treatment at
home using the ginger patch only as required for a
further 24 weeks. The ginger patch was used by all
participants for self-treatments because it is simple
to apply, as well as convenient and reliable. The
ginger compress is awkward and difficult to prepare
in a consistent and reliable manner by patients.
Participants were educated in the use of the ginger
patch, with adequate supplies of patches available
from the clinics. The MHAQ was completed four
times a week for 24 weeks either in person or by
telephone, depending on participant availability.
This study has appropriate state ethical approval
in New Zealand. All participants gave their informed,
signed consent to be part of the study, and all identification is anonymous.

Sample
The sample comprised 20 consenting Caucasian
adults diagnosed with chronic symptomatic OA in
any site for at least 1 year. Advertisements went to
community groups and medical centers in two New
Zealand cities. OA was confirmed by Kellgren and
Lawrence X-ray Grades 2 and 3; health assessment
was based on clinical diagnosis and completion of
the short arthritis assessment scale (SAS; Wolfe,
Michaud, Kahler, & Omar, 2004). The SAS asks
four simple questions relating to pain, functional
status, and global effect of OA in the previous week,
each on a 10-point Likert-type scale, with 0 for no
problem and 10 for very severe problem. No participant was accepted with a pain score less than 5/10

or a total score less than 18/40. The health assessment excluded those with a joint replacement of the
affected joint, rheumatoid arthritis, fibromyalgia,
cancer, and other serious health conditions; those
who were not naive to the therapy; and those having
corticosteroids and/or anticoagulants in the past 12
weeks. This same selection method proved effective
in a previous ginger compress qualitative study
(Therkleson, 2010a).

Data Collection
This study uses three brief SRQ that have been
found reliable and valid in rheumatology: (a) SAS,
(b) modified MHAQ, and (c) daily pain questionnaire for 21 days.
The SAS (Wolfe, Michaud, Kahler, et al., 2004)
was used solely to confirm selection of participants.
The SAS is designed specifically to assess OA symptoms quickly and effectively in the clinical and
research setting (Wolfe, Michaud, Kahler, et al.,
2004).
The MHAQ was completed 7 days before topical
ginger treatments, within 12 hours after the treatments, 7 days later, and 4 weekly for 24 weeks. The
MHAQ was prepared by the National Data Bank for
Rheumatic Diseases to be used as a simple, brief
questionnaire in the clinical and research setting. It
was effective in the prospective Arthritis Outcomes
Study led by Wolfe, Pincus, Thompson, and Doyle
(2003). The MHAQ is one page long and asks 14
simple questions relating to the past week: (a) 3
independent questions on pain, fatigue, and global
effect each recorded on a 10-cm visual analog scale
(VAS); (b) 10 questions on functional status recorded
on the Health Assessment Questionnaire–II
(HAQ-II; Wolfe, Michaud, & Pincus, 2004); and (c)
one question on health satisfaction recorded on a
categorical scale. The HAQ-II has 10 items and was
developed as a brief and simplified version of the
original HAQ (Bruce & Fries, 2003a, 2003b) disability index used in rheumatology.
The daily pain scale was completed for 21 consecutive days (7 days before therapy, 7 days during
therapy, and 7 days after therapy) on a 10-cm VAS,
with 0 for no problem and 10 for very severe problem. The 10-cm VAS is recognized in rheumatology
as the most robust quantitative pain measure (Sokka,
2003; Tuulikki, 2003). Changes in pain relief medication were also recorded daily below the scale. The
additional data relating to medication provide
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increased understanding of the changes in OA status before and after topical ginger therapy.
Participant total mean scores are given for the
three questions on a VAS and the HAQ-II, with proportions for the one categorical variable. MHAQ
total scoring was out of 3, with each of the questions
on the 10-cm VAS and the 10 questions on the
HAQ-II totaling 3. The 21-day pain scale was scored
from 0 to 3, with 0 being no problem and 3 being a
severe problem. The HAQ-II has 10 items with each
scored from 0 to 3: 0 to 1 is mild to moderate disability, 1 to 2 is moderate to severe disability, and 2 to
3 is severe to very severe disability. The total HAQ-II
score is divided by 10, resulting in 3 being the highest score possible in functional status. By maintaining consistency in the scoring of each question, it
was possible to compare the final scores of the
groups.

Results
The sample size is small limiting formal statistical testing; nonetheless means, standard deviation
(SD), standard error bars, and % differences are
given. Excel software was used to analyze the data.
The sample comprised 20 consenting Caucasian
adults with varying characteristics and OA status at
baseline. Participants, mean age 64 years, 80%
female, had a mean pain score at baseline of 6.8,
with 10 being the most extreme pain; mean pain
score for Group 1 was 6/10 and for Group 2 7/10.
Most participants had OA of the hips and/or knees
(17/20, 85%), whereas the remainder in the hands,
shoulder, cervical, and lumbar regions for a mean of
8 years, SD of 6. Sixteen participants were from
participating medical practices and 4 from the community. The SAS was quick and simple to complete,
easily scored and effective in confirming selection.
Total SAS scores ranged from 36/40 to 18/40, with
a mean score of 26/40 and SD of 4.5; mean of
Group 1 was 6/10 and Group 2 was 7/10.
The MHAQ was well received by participants; it
was brief and easily completed. The 21-day pain
VAS gave added confidence in scoring pain on the
MHAQ.
Part 1: The mean MHAQ scores for Groups 1
and 2 show a notable decline after topical
ginger treatment; Group 1 was 1.75/3 at
baseline and 1.15/3 one week after therapy,

whereas Group 2 was 1.85/3 at baseline and
0.95/3 one week after therapy (see Figure 1).
Part 2: Following the week of topical ginger
compress treatments in the clinics, Group 1 is
identified as Group 1a and is now using only
ginger patches as is Group 2. Figure 1 shows the
mean MHAQ scores, excluding health
satisfaction status for Groups 1a and 2, 4 weekly
for 24 weeks on a line plot with error bars.

The mean MHAQ scores indicate a positive
response after 1 week treatment on the VAS in pain,
fatigue, and global effect, with percentage responses
of 48%, 49%, and 40%, respectively, and on the
HAQ-II for functional status 31%. Tubach et al.
(2005) state that a meaningful clinical improvement
in knee and hip OA for pain on the 10-cm VAS is
40.8% to 32% and global effect on the 10-cm VAS
39% to 32%, whereas functional status on Western
Ontario and McMaster Universities Osteoarthritis
Index function is 26% to 21%. Figures 2 to 5 show
box plots for Group 1/1a and Group 2 with standard
error bars for each of the four domains of the
MHAQ—pain, fatigue, functional status, and global
effect—over the 27-week study. At baseline, the
median in all four domains varied from 2.4 to 1.2/3,
and after 27 weeks, it was below 0.4/3 in all domains.
The final question for health satisfaction status
on a categorical scale indicates a positive shift, with
80% dissatisfied 7 days before therapy, 70% satisfied
7 days after therapy, and 82% satisfied 24 weeks
after self-treatment (see Table 1).
During the initial 3-week study, the daily mean
pain scores compared favorably with the weekly
MHAQ mean pain scores, with a SD of 0.01. The
baseline mean pain score for all participants was
2.2/3, then 7 days after therapy the mean was
0.95/3. All participants in the sample registered a
reduction in pain no matter what happened (medication taken, activity level, and degree of severity of
symptoms). Medication for pain relief decreased
during the study. At commencement, 6 participants
took no pain relief, and 14 took conventional analgesics as required. After 7 days of ginger therapy, 5
of the 14 participants continued their usual medication regime, whereas 9 stopped all forms of analgesia; then 4 weeks later, 11 participants reported
requiring no further pain relief as previously
required. After 4 weeks, 78% of those previously taking analgesia were no longer requiring this additional support.
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3.0

Excludes Sasfacon Score
Group 1
Group 1a
Group 2
Maximum
Minimum

Mean MHAQ Score

2.5

2.0

1.5

1.0

0.5

0.0

7 days
24 hours
before
aer
treatment treatment

1 week

4 weeks

8 weeks

12 weeks 16 weeks 20 weeks 24 weeks

Figure 1. Mean MHAQ Scores for Groups 1/1a and 2
Note: MHAQ = Modified Health Assessment Questionnaire.

3.0
Group 1 Compress
2.5

Group 1a Patch
Group 2 Patch
Median

2.0

Maximum

Pain Score

Minimum
1.5

1.0

0.5

0.0
7 days before
treatment

7 days aer
treatment

Figure 2. MHAQ Mean Pain Scores for Groups 1/1a and 2
Note: MHAQ = Modified Health Assessment Questionnaire.

12 weeks aer
treatment

24 weeks aer
treatment
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3.0
Group 1 Compress
2.5

Group 1a Patch
Group 2 Patch
Median

Fague Score

2.0

Maximum
Minimum

1.5

1.0

0.5

0.0
7 days before
treatment

7 days aer
treatment

12 weeks aer
treatment

24 weeks aer
treatment

Figure 3. MHAQ Mean Fatigue Scores for Groups 1/1a and 2
Note: MHAQ = Modified Health Assessment Questionnaire.

3.0

Group 1 Compress

2.5

Group 1a Patch

Funconal Status Score

Group 2 Patch
2.0

Median
Maximum
Minimum

1.5

1.0

0.5

0.0

7 days before
treatment

7 days aer
treatment

Figure 4. MHAQ Mean Functional Status Scores for Groups 1/1a and 2
Note: MHAQ = Modified Health Assessment Questionnaire.

12 weeks aer
treatment

24 weeks aer
treatment
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3.0
Group 1 Compress
2.5

Group 1a Patch
Group 2 Patch
Median

Global Effect Score

2.0

Maximum
Minimum

1.5

1.0

0.5

0.0
7 days before
treatment

7 days aer
treatment

12 weeks aer
treatment

24 weeks aer
treatment

Figure 5. MHAQ Mean Global Effect Scores for Groups 1/1a and 2
Note: MHAQ = Modified Health Assessment Questionnaire.

Table 1. MHAQ Health Satisfaction, Groups 1/1a and 2

Very satisfied
Somewhat satisfied
Neither satisfied nor dissatisfied
Somewhat dissatisfied
Very dissatisfied

7 Days Before
Therapy

7 Days After
Therapy

12 Weeks
After Therapy

24 Weeks
After Therapy

0%
5%
15%
45%
35%

20%
50%
5%
20%
5%

26%
58%
5%
11%
0%

39%
44%
6%
11%
0%

Note: MHAQ = Modified Health Assessment Questionnaire.

The 20 participants were motivated to be 100%
compliant in every aspect of the study, and there
were no reported adverse effects from nurses or participants. One participant did not continue selftreatment due to comorbidities that compromised
the ability to maintain a balanced perspective, when
completing the SRQ.

Limitations
Although this study shows a positive response to
topical ginger therapy, the small numbers do not

allow for clinical significance. There are a number
of limitations because this is
• A study with no specific hypothesis.
• A small sample based in one culture with
treatments given in four selected medical
practices. A larger participant sample from a
wider pool would avoid biases and support
statistically based generalizations.
• A sample with a variation of OA sites. A study
centering on a single OA site would provide a
more even cohort.
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• An open-label, two-group design, with no
control for observational biases, natural
history, or maturation.
• A treatment that includes rest, warmth, and
relationship to the nurse and the researcher.

Discussion
This study extends previous qualitative research
on topical ginger treatments that reported the warming and relaxing experience of topical ginger compresses (Therkleson, 2010b; Therkleson & Sherwood,
2004). The same procedure is used as with previous
research of the ginger compress, while the manually
prepared ginger compress is evaluated alongside a
standardized ginger patch by using simple, brief
SRQs. Results show the ginger patch worked as well
as the compress, irrespective of medication taken,
level of activity, and degree of severity of symptoms.
Previous research for people with OA has shown the
significance of relaxation and warmth physically and
emotionally (Baird & Sands, 2006; Cantarini et al.,
2007; Chen et al., 2010; Morone & Greco, 2007)
and that chronic pain leads to difficulties with cognitive functioning and psychological well-being
(Dohrenbusch, Buchanan, Lipka, & Ott, 2008;
Mouchnino et al., 2005; Smith & Zautra, 2008).
Results from this study are consistent with this
research; participants prior to topical ginger treatments suffered extreme chronic pain, fatigue, exhaustion, and dissatisfaction with their health status.
Pain on movement is the primary symptom of OA,
and pain is considered the most important category of
body functionality in the International Classification
of Function, Disability and Health (Stucki et al.,
2002). This study showed a significant shift in pain
symptoms by using the 10-cm VAS pain scoring daily
for 21 days, and the MHAQ 7 days before and 7 days
after therapy. Considering that a 30% reduction in
pain on a VAS is meaningful, this study’s results are
notable (Kelly, 2001). Participants reported a reduction in chronic fatigue, dissatisfaction with health
status, and overall global effect of OA, as well as pain
and functional status. Topical ginger treatments are
reportedly effective in managing chronic respiratory
and metabolic problems as well as anxiety and depressive disorders (Fingado, 2012) and have no known
side effects, which improves its profile over the use of
nonsteroidal anti-inflammatory drugs, COX-2 inhibitors, and analgesics for people with OA. Topical ginger

is not found to have the negative effects of internal
ginger administration for people with OA (Marcus &
Suarez-Almazor, 2001) or the peripheral anesthesia
caused by topical capsaicin (Dedov et al., 2002).
Caution must be used in considering these
results as chronic pain is the one condition in which
a statistically significant effect is observed when a
placebo is used for patients with OA. Systematic
reviews on the reported placebo effect in randomized control trials for patients with OA found that
the placebo is very effective in treating self-report
pain, stiffness, and functionality in patients with OA
(Zeidler, 2011; Zhang, Robertson, Jones, Dieppe, &
Doherty, 2008). Although this is an important factor,
it needs to be considered alongside the results of
this study, where participants reported a significant
reduction in chronic fatigue, dissatisfaction with
health status, overall global effect of OA, as well as
analgesia, pain, and functional status.
In this study, the topical application of ginger was
distal to the OA site, which suggests systemic absorption. The active ingredients of ginger (gingerols and
shogaols) have a molecular weight of 150 to 190 Da,
a lipophilicity log P range 3.5, and moderate solubility in water and oil, which allows good potential for
skin penetration (Jolad et al., 2004; Minghetti et al.,
2007). Studies on human skin using ginger extract
show evidence of absorption. Ginger extract was
absorbed in human epithelial tissue and inhibited
COX-2 (Tjendraputra, Tran, Liu-Brennan, Roufogalis,
& Duke, 2001), and Mingetti et al. (2007) found that
a gingerol extract on a plaster was absorbed transdermally through human epidermis as well as having an
effective anti-inflammatory response on mouse skin.
Mingetti et al. conclude there would likely be an
anti-inflammatory effect with the transdermal delivery of ginger.
Topical ginger treatments offer a novel approach
to managing the debilitating symptoms of OA. The
mechanism of action is likely a combination of
increased warmth and relaxation, systemic absorption of the ginger, and the placebo effect resulting
from receiving the intervention along with the
opportunity to self-treat in the home.

Conclusion
Topical ginger on the mid-lumbar region is a simple treatment that has the potential to manage the
complex range of symptoms experienced by people
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with OA. Manually prepared compresses and standardized patches applied for 7 consecutive days
decreased symptoms of pain and disability for 20
adults with OA. This positive response continued
over the following 24 weeks, with self-treatment.
Topical ginger treatments were found to improve the
subdimensions of quality of life scores of physical
function, pain, and health satisfaction and overall
global effect of OA. The noninvasive nature of topical ginger avoids the risks of conventional medication and surgery and has the potential to delay and
possibly negate the use of these more invasive treatments. This study advances previous qualitative
studies on topical ginger for OA by using brief and
simple SRQs. Although a small sample, the positive
response warrants further controlled research with a
larger and more even cohort.
The domain of topical ginger is those people
with OA for whom existing treatments are unsatisfactory due to personal preference, complex comorbidities, and/or existing medication regimes. The
wide range of symptoms, ongoing debilitating effect,
and absence of a cure means people with OA are
often prepared to consider a range of options,
including alternative approaches. Topical ginger
treatments are a convenient, simple, and economical option that needs to be considered in the care of
the aged with OA.
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